158 related articles for article (PubMed ID: 17867604)
21. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder.
Cheng L; MacLennan GT; Zhang S; Wang M; Pan CX; Koch MO
Cancer; 2004 Jul; 101(1):183-8. PubMed ID: 15222005
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
[TBL] [Abstract][Full Text] [Related]
23. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin.
Sung MT; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R; Wang M; Tan PH; Cheng L
Clin Cancer Res; 2008 Apr; 14(7):1947-55. PubMed ID: 18381932
[TBL] [Abstract][Full Text] [Related]
24. Significance of denuded urothelium in papillary urothelial lesions.
Owens CL; Epstein JI
Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer.
Arentsen HC; de la Rosette JJ; de Reijke TM; Langbein S
Expert Rev Mol Diagn; 2007 Jan; 7(1):11-9. PubMed ID: 17187480
[TBL] [Abstract][Full Text] [Related]
26. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
27. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
28. Genomic imbalances in urothelial cancer: intratumor heterogeneity versus multifocality.
Prat E; Del Rey J; Camps J; Ponsa I; Lloreta J; Egozcue J; Gelabert A; Campillo M; Miro R
Diagn Mol Pathol; 2008 Sep; 17(3):134-40. PubMed ID: 18382360
[TBL] [Abstract][Full Text] [Related]
29. Molecular and histological markers in urothelial carcinomas of the upper urinary tract.
Eltz S; Comperat E; Cussenot O; Rouprêt M
BJU Int; 2008 Aug; 102(5):532-5. PubMed ID: 18384628
[TBL] [Abstract][Full Text] [Related]
30. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
Lane Z; Epstein JI
Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
[TBL] [Abstract][Full Text] [Related]
31. Y chromosome loss is a frequent early event in urothelial bladder cancer.
Minner S; Kilgué A; Stahl P; Weikert S; Rink M; Dahlem R; Fisch M; Höppner W; Wagner W; Bokemeyer C; Terracciano L; Simon R; Sauter G; Wilczak W
Pathology; 2010 Jun; 42(4):356-9. PubMed ID: 20438408
[TBL] [Abstract][Full Text] [Related]
32. Short telomeres and chromosome instability prior to histologic malignant progression and cytogenetic aneuploidy in papillary urothelial neoplasms.
Izumiyama-Shimomura N; Nakamura K; Aida J; Ishikawa N; Kuroiwa M; Hiraishi N; Fujiwara M; Ishikawa Y; Inoshita N; Yonese J; Matsuura M; Poon SS; Arai T; Takubo K
Urol Oncol; 2014 Feb; 32(2):135-45. PubMed ID: 23510865
[TBL] [Abstract][Full Text] [Related]
33. Molecular characteristics of urothelial neoplasms in children and young adults: a subset of tumors from young patients harbors chromosomal abnormalities but not FGFR3 or TP53 gene mutations.
Williamson SR; Wang M; Montironi R; Eble JN; Lopez-Beltran A; Zhang S; Fan R; Wang L; Osunkoya AO; Koch MO; Cheng L
Mod Pathol; 2014 Nov; 27(11):1540-8. PubMed ID: 24743222
[TBL] [Abstract][Full Text] [Related]
34. Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase-immortalized urothelial cells (TERT-NHUC).
Chapman EJ; Williams SV; Platt FM; Hurst CD; Chambers P; Roberts P; Knowles MA
Genes Chromosomes Cancer; 2009 Aug; 48(8):694-710. PubMed ID: 19405089
[TBL] [Abstract][Full Text] [Related]
35. Multicolor FISH and cytometric analyses allow classification of urothelial carcinomas into two subtypes, low- and high-grade tumors.
Ikemoto K; Furuya T; Matsuda K; Kawauchi S; Oga A; Ikeda J; Liu XP; Sasaki K
Int J Oncol; 2004 Oct; 25(4):893-8. PubMed ID: 15375537
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of microsatellite instability determined by immunohistochemical staining of hMSH2 and hMSH6 in urothelial carcinoma of the bladder.
Mylona E; Zarogiannos A; Nomikos A; Giannopoulou I; Nikolaou I; Zervas A; Nakopoulou L
APMIS; 2008 Jan; 116(1):59-65. PubMed ID: 18254781
[TBL] [Abstract][Full Text] [Related]
37. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract.
Hafner C; Knuechel R; Zanardo L; Dietmaier W; Blaszyk H; Cheville J; Hofstaedter F; Hartmann A
Oncogene; 2001 Aug; 20(35):4910-5. PubMed ID: 11521204
[TBL] [Abstract][Full Text] [Related]
38. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis.
Jones TD; Zhang S; Lopez-Beltran A; Eble JN; Sung MT; MacLennan GT; Montironi R; Tan PH; Zheng S; Baldridge LA; Cheng L
Am J Surg Pathol; 2007 Dec; 31(12):1861-7. PubMed ID: 18043040
[TBL] [Abstract][Full Text] [Related]
39. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
40. Molecular cytogenetic characterization and diagnostics of bladder cancer.
Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]